BTG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.13579999960756E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.85619972117956E-10 |
Normal-vs-Stage2 |
1.11989999995732E-06 |
Normal-vs-Stage3 |
3.48009999706633E-08 |
Normal-vs-Stage4 |
7.222600E-04 |
Stage1-vs-Stage2 |
8.387000E-01 |
Stage1-vs-Stage3 |
1.979360E-01 |
Stage1-vs-Stage4 |
9.139600E-01 |
Stage2-vs-Stage3 |
5.964200E-01 |
Stage2-vs-Stage4 |
9.620800E-01 |
Stage3-vs-Stage4 |
6.677000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.80769999869446E-08 |
Normal-vs-AfricanAmerican |
1.608740E-04 |
Normal-vs-Asian |
9.162800E-03 |
Caucasian-vs-AfricanAmerican |
1.702180E-01 |
Caucasian-vs-Asian |
6.216200E-01 |
AfricanAmerican-vs-Asian |
5.703200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.02519999448603E-08 |
Normal-vs-Female |
9.62139999893807E-08 |
Male-vs-Female |
1.375780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.51330000039718E-07 |
Normal-vs-Extreme_Weight |
3.27279999767782E-08 |
Normal-vs-Obese |
3.28579999875345E-08 |
Normal-vs-Extreme_Obese |
8.91630003163613E-09 |
Normal_Weight-vs-Extreme_Weight |
2.670600E-01 |
Normal_Weight-vs-Obese |
2.434000E-01 |
Normal_Weight-vs-Extreme_Obese |
6.307900E-02 |
Extreme_Weight-vs-Obese |
9.352800E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.800450E-01 |
Obese-vs-Extreme_Obese |
3.561200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.616300E-03 |
Normal-vs-Age(41-60Yrs) |
8.24820000078219E-08 |
Normal-vs-Age(61-80Yrs) |
1.38770000046584E-07 |
Normal-vs-Age(81-100Yrs) |
1.27010000294803E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.381580E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.776590E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.636100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.527000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.407600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.69760000396013E-08 |
Normal-VS-Type2 PRCC |
3.36419999968918E-07 |
Normal-VS-KIRP CIMP |
2.726500E-02 |
Normal-VS-Unclassified PRCC |
6.37339999665087E-08 |
Type1 PRCC-VS-Type2 PRCC |
2.956800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.070220E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.266800E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.049200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
4.866200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.364360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.06980000203328E-08 |
Normal-vs-N1 |
4.86669999855138E-08 |
Normal-vs-N2 |
2.823000E-01 |
N0-vs-N1 |
8.914000E-01 |
N0-vs-N2 |
2.365000E-01 |
N1-vs-N2 |
2.303400E-01 |
|
|